Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0039 USD | +2.63% | -13.33% | -87.00% |
Quotes 5-day view
Delayed Quote OTC Markets28/05/2024 | 29/05/2024 | 30/05/2024 | |
---|---|---|---|
Last | 0.004236 $ | 0.0038 $ | 0.0039 $ |
Volume | 96 941 | 130 012 | 373 261 |
Change | +∞% | -10.29% | +2.63% |
Opening | 0.00 | 0.00 | 0.00 |
High | 0.00 | 0.00 | 0.00 |
Low | 0.00 | 0.00 | 0.00 |
Performance
1 day | +2.63% | ||
1 week | -13.33% | ||
1 month | -35.00% | ||
3 months | -72.14% | ||
6 months | -79.03% | ||
Current year | -87.00% | ||
1 year | -96.75% | ||
3 years | -99.58% | ||
5 years | -99.90% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+2.63% | -13.33% | -87.00% | -96.75% | 45.34K | ||
+0.07% | +2.90% | +15.55% | +40.87% | 121B | ||
+0.12% | +0.45% | +12.66% | +33.72% | 107B | ||
-0.74% | +6.11% | -2.53% | -4.86% | 24.82B | ||
-0.09% | +2.81% | +1.08% | -7.24% | 22.48B | ||
-0.44% | +0.78% | -9.54% | -28.93% | 18.32B | ||
-0.26% | -0.99% | -42.28% | -38.09% | 16.33B | ||
+1.38% | -4.24% | -18.92% | -35.68% | 15.31B | ||
-0.86% | +0.37% | +6.19% | +51.56% | 14.08B | ||
-1.55% | +0.62% | +28.83% | -0.74% | 11.74B | ||
-0.10% | +154.27% | +80.51% | +186.28% | 9.02B | ||
-0.70% | +4.93% | +14.89% | +42.22% | 7.85B | ||
-0.24% | +3.76% | +7.43% | +48.20% | 7.76B | ||
+0.06% | -1.69% | -4.17% | +21.72% | 7.4B | ||
+0.49% | -3.33% | -33.47% | -36.84% | 7.3B | ||
+1.41% | -0.76% | +234.61% | +179.49% | 6.87B | ||
Average | +0.18% | +10.26% | +12.74% | +22.18% | ||
Weighted average by Cap. | -0.06% | +4.87% | +11.85% | +27.19% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -87.00% | ||
2023 | -96.34% | ||
2022 | -44.60% | ||
2021 | +78.31% | ||
2020 | -28.45% | ||
2019 | -79.29% | ||
2018 | -83.03% | ||
2017 | +10.00% | ||
2016 | +50.00% |
- Stock Market
- Equities
- ATRX Stock
- Quotes Adhera Therapeutics, Inc.